Back to SI SB Investment Advisers (UK) Ltd.

VIRVIR

Showing 8 of 27 quarters

Position history for SISB Investment Advisers (UK) Ltd.'s holdings in Vir Biotechnology, Inc.

Yes. SB Investment Advisers (UK) holds 10,948,093 shares of VIR (Vir Biotechnology), worth $111.6M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. SB Investment Advisers (UK) has held VIR in every 13F on record since Q4 2019, 27 quarterly filings. VIR is 1.5% of SB Investment Advisers (UK)'s reported 13F portfolio.

Current Value

$111.6M

Current Shares

10.9M

Total Value Change

-$13.4M

Total Shares Change

-5.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
10.9M
0.0%
$111.6M1.5%$10.19
0
2026-Q1
Decreased
10.9M
-16.5%
$98.1M1.3%$8.91
0
2025-Q4
Decreased
13.1M
-21.4%
$79.1M0.8%$5.84
0
2025-Q3
Unchanged
16.7M
0.0%
$95.3M0.7%$5.63
0
2025-Q2
Unchanged
16.7M
0.0%
$84.1M0.7%$5.17
0
2025-Q1
Unchanged
16.7M
0.0%
$108.1M1.0%$6.70
0
2024-Q4
Unchanged
16.7M
0.0%
$122.5M1.1%$7.33
0
2024-Q3
Unchanged
16.7M
0.0%
$125M1.0%$7.53
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used